Aktie FERVENTSYN6 FERVENT SYNERGIES LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Fervent Synergies Limited

Aktien

FERVENTSYN6

INE258M01011

FERVENTSYN6

Verzögert Bombay S.E.
Andere Börsenplätze
 11:43:59 26.06.2024 		% 5 Tage % 1. Jan.
16,4 INR -0,91 % Intraday Chart für Fervent Synergies Limited -3,64 % -26,52 %
09.05. Fervent Synergies mit Verlust im vierten Quartal; Aktien fallen um 5% MT
09.05. Fervent Synergies Limited meldet Ergebnis für das vierte Quartal bis zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Fervent Synergies Swings to Loss in Fiscal Q4; Shares Drop 5%
Fervent Synergies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
Fervent Synergies Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Fervent Synergies Limited Appoints Nehal Bharat Mehta as Company Secretary and Compliance Officer
Fervent Synergies Limited Announces Resignation of Pooja Sanghavi as Company Secretary / Compliance Officer
Fervent Synergies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Fervent Synergies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Fervent Synergies Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Fervent Synergies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Fervent Synergies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Fervent Synergies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Fervent Synergies Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Fervent Synergies Swings to Loss in Fiscal Q4
Fervent Synergies Limited Reports Earnings Results for the Full Year Ended March 31, 2022
Fervent Synergies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
Fervent Pharmaceuticals Commences Virtual at Home Phase 2 Clinical Trial of a Peri- and Post-Menopausal Therapy for Treating Hot Flashes and Night Sweats
Fervent Synergies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
Fervent Synergies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
Fervent Synergies Limited Reports Earnings Results for the First Quarter Ended June 30, 2021
Fervent Synergies' : Net Profit Jumps in Fiscal Q4
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. FERVENTSYN6 Aktie
  4. Nachrichten Fervent Synergies Limited
  5. Andere Sprachen